What Researchers Did
Researchers at Kuibyshev Medical Institute studied hyperbaric oxygen therapy for patients with ankylosing spondylarthritis over a 10-year period.
What They Found
They observed positive changes in 94.4% of the 142 patients treated with hyperbaric oxygen therapy. These improvements included better breathing, performance status, and positive changes in electromyographic, laboratory, biochemical, and immunological tests.
Canadian Relevance
No direct Canadian connection identified. Ankylosing spondylarthritis is not a Health Canada-recognised indication for HBOT.
Study Limitations
The study abstract lacks details on the specific hyperbaric oxygen therapy protocols used and does not mention a control group for comparison.